There are some skin conditions we're very familiar with: spots during adolescence, allergic rashes, sunburn. But others are ...

Rosacea treatment is a marathon — not a sprint — and there’s a need for increased emphasis on a patient-centric approach to management that emphasizes patient education and individualized treatment ...

“NRS-funded studies discovered that abnormal production of cathelicidins led to inflammatory lesions in rosacea patients, as well as vascular effects such as flushing and telangiectasia,” Huff ...

U.S. FDA approved EmrosiTM (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the tr ...

In the Minocycline Versus Oracea® in Rosacea-1 (MVOR-1 ... treatment success and the reduction in total inflammatory lesion count from baseline to Week 16. Secondary endpoints included the ...

The FDA approved Emrosi for the treatment of inflammatory lesions of rosacea in adults in November 2024. Interested parties are invited to visit Journey Medical’s booth 2181 to learn about ...

Your favorite comfort foods could be causing breakouts, premature aging, and skin inflammation. Discover the 4 worst dietary ...

U.S. FDA approved Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the treatment of inflammatory lesions of rosacea in adults ...

The global dermatology lasers market is set for substantial growth, increasing from USD 1,767.8 billion in 2023 to USD ...